Publications by authors named "Sheila Peters"

Claim this Profile
I
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global Convergence.
Kellie Reynolds, Xinning Yang, Sheila Annie Peters, Vikram Sinha, Helen Heymann

Clin Pharmacol Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quest to define cancer-specific systems parameters for personalized dosing in oncology.
Areti-Maria Vasilogianni, Brahim Achour, Zubida M Al-Majdoub, Sheila Annie Peters, Jill Barber

Expert Opin Drug Metab Toxicol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.
André Dallmann, Denise Feick, Pavel Balazki, Salih Benamara, Rolf Burghaus, Sheila Peters

CPT Pharmacometrics Syst Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs.
Karine Rodriguez-Fernandez, José David Gómez-Mantilla, Suneet Shukla, Peter Stopfer, Peter Sieger, Sheila Annie Peters

Clin Pharmacokinet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solubility-Limited Absorption Identified by a Simplified PBPK Model for the Prediction of Positive Food Effect for BCS II/IV Drugs.
Karine Rodriguez-Fernandez, José David Gómez-Mantilla, Suneet Shukla, Victor Mangas-Sanjuán, Sheila Annie Peters

Clin Pharmacokinet· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Mechanistic Static Models for Drug-Drug Interactions Support Regulatory Filing for Study Waivers and Label Recommendations?
Jose David Gomez-Mantilla, Fenglei Huang, Sheila Annie Peters

Clin Pharmacokinet· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis.
Areti-Maria Vasilogianni, Zubida M Al-Majdoub, Brahim Achour, Sheila Annie Peters, Amin Rostami-Hodjegan

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects.
Areti-Maria Vasilogianni, Zubida M Al-Majdoub, Brahim Achour, Sheila Annie Peters, Amin Rostami-Hodjegan

Br J Clin Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective.
Tycho Heimbach, Yuan Chen, Jun Chen, Vaishali Dixit, Neil Parrott, Sheila Annie Peters

Clin Pharmacol Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver Metastasis.
Areti-Maria Vasilogianni, Brahim Achour, Daniel Scotcher, Sheila Annie Peters, Zubida M Al-Majdoub

Drug Metab Dispos· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of active human dose: learnings from 20 years of Merck KGaA experience, illustrated by case studies.
Sheila Annie Peters, Carl Petersson, Andree Blaukat, Joern-Peter Halle, Hugues Dolgos

Drug Discov Today· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Requirements to Establishing Confidence in Physiologically Based Pharmacokinetic (PBPK) Models and Overcoming Some of the Challenges to Meeting Them.
Sheila Annie Peters, Hugues Dolgos

Clin Pharmacokinet· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the Design of Clinical Drug-Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically-Based Pharmacokinetic Model.
Yuan Chen, Tamara D Cabalu, Ernesto Callegari, Heidi Einolf, Lichuan Liu, Sheila Annie Peters

CPT Pharmacometrics Syst Pharmacol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically-Based Pharmacokinetics for Pediatric Dosing Using Clearance as a Surrogate.
Qier Wu, Sheila Annie Peters

CPT Pharmacometrics Syst Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.
Mohamad Shebley, Punam Sandhu, Arian Emami Riedmaier, Masoud Jamei, Rangaraj Narayanan, Sheila Annie Peters

Clin Pharmacol Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative evaluation of models to predict human intestinal metabolism from nonclinical data.
Estelle Yau, Carl Petersson, Hugues Dolgos, Sheila Annie Peters

Biopharm Drug Dispos· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models.
Sheila Annie Peters, Christopher R Jones, Anna-Lena Ungell, Oliver J D Hatley

Clin Pharmacokinet· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination.
Christopher R Jones, Oliver J D Hatley, Anna-Lena Ungell, Constanze Hilgendorf, Sheila Annie Peters

AAPS J· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of in vitro systems and preclinical data for the prediction of human intestinal first-pass metabolism during drug discovery and preclinical development.
Fredrik H Karlsson, Salim Bouchene, Constanze Hilgendorf, Hugues Dolgos, Sheila Annie Peters

Drug Metab Dispos· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-based drug discovery: implementation and impact.
Sandra A G Visser, Malin Aurell, Rhys D O Jones, Virna J A Schuck, Ann-Charlotte Egnell, Sheila A Peters

Drug Discov Today· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exhaled nitric oxide monitoring does not reduce exacerbation frequency or inhaled corticosteroid dose in paediatric asthma: a randomised controlled trial.
Katharine Pike, Anna Selby, Sophie Price, John Warner, Gary Connett, Sheila Peters

Clin Respir J· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the use of static and dynamic models to predict drug-drug interaction and its associated variability: impact on drug discovery and early development.
Sheila Annie Peters, Patricia E Schroeder, Nagdeep Giri, Hugues Dolgos

Drug Metab Dispos· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health experiences of adolescents with uncontrolled severe asthma.
Kate Edgecombe, Sue Latter, Sheila Peters, Graham Roberts

Arch Dis Child· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of input parameters on the prediction of hepatic plasma clearance using the well-stirred model.
Hong Wan, Peter Bold, Lars-Olof Larsson, Johan Ulander, Sheila Peters

Curr Drug Metab· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
Sheila Annie Peters, Anna-Lena Ungell, Hugues Dolgos

Curr Opin Drug Discov Devel· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis